These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35193824)

  • 21. [Regulatory science research to facilitate the development of cell/tissue-processed products].
    Sato Y; Tsutsumi H; Sawada R; Suzuki T; Yasuda S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):16-9. PubMed ID: 24340665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products.
    Hayakawa T; Aoi T; Bravery C; Hoogendoorn K; Knezevic I; Koga J; Maeda D; Matsuyama A; McBlane J; Morio T; Petricciani J; Rao M; Ridgway A; Sato D; Sato Y; Stacey G; Sakamoto N; Trouvin JH; Umezawa A; Yamato M; Yano K; Yokote H; Yoshimatsu K; Zorzi-Morre P
    Biologicals; 2015 Sep; 43(5):283-97. PubMed ID: 26315651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Trends in Clinical Development of Gene and Cellular Therapeutic Products for Cancer in Japan.
    Nagai S; Sugiyama D
    Clin Ther; 2019 Jan; 41(1):174-184.e3. PubMed ID: 30528048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry updates from the field of stem cell research and regenerative medicine in February 2020.
    Ilic D; Liovic M
    Regen Med; 2020 Jun; 15(6):1689-1694. PubMed ID: 32290767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of the clinical application of regenerative medicine products in Japan.
    Tsubouchi M; Matsui S; Banno Y; Kurokawa K; Kawakami K
    Health Policy; 2008 Oct; 88(1):62-72. PubMed ID: 18395290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regenerative medicine legislation in Japan for fast provision of cell therapy products.
    Fujita Y; Kawamoto A
    Clin Pharmacol Ther; 2016 Jan; 99(1):26-9. PubMed ID: 26482927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings: international regulatory considerations on development pathways for cell therapies.
    Feigal EG; Tsokas K; Viswanathan S; Zhang J; Priest C; Pearce J; Mount N
    Stem Cells Transl Med; 2014 Aug; 3(8):879-87. PubMed ID: 25038248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan.
    Nagai S
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
    Bakopoulou A
    J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
    Azuma K; Yamanaka S
    Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
    Ciccocioppo R; Dos Santos CC; Baumgart DC; Cangemi GC; Cardinale V; Ciacci C; De Coppi P; Haldar D; Klersy C; Nostro MC; Ott M; Piemonti L; Tomei AA; Uygun B; Vetrano S; Orlando G
    Cytotherapy; 2018 Mar; 20(3):461-476. PubMed ID: 29398624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory Trends in Drug Development in Asia Pacific.
    Han FV; Weiss K
    Ther Innov Regul Sci; 2019 Jul; 53(4):497-501. PubMed ID: 30249120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.
    Chavez J; Shah NA; Ruoss S; Cuomo RE; Ward SR; Mackey TK
    Stem Cell Res Ther; 2021 Mar; 12(1):189. PubMed ID: 33736697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eighth symposium on biologic scaffolds for regenerative medicine.
    Dearth CL
    Regen Med; 2014; 9(5):569-72. PubMed ID: 25372075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulating the therapeutic translation of regenerative medicine.
    Cuchiara ML; Olive JK; Matthews K
    Expert Opin Biol Ther; 2015; 15(10):1387-90. PubMed ID: 26144546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development.
    Bertram TA; Johnson PC; Tawil BJ; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2015 Oct; 21(19-20):2476-9. PubMed ID: 26222734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ideal way to design clinical trials and establishment of evidence for human cellular and tissue-based products in Japan.
    Sawa Y
    J Tissue Eng Regen Med; 2019 Jun; 13(6):905-907. PubMed ID: 30938062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan.
    Kawase T; Okuda K
    Biomed Res Int; 2018; 2018():6389157. PubMed ID: 29951539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.
    Takashima K; Morrison M; Minari J
    Stem Cell Reports; 2021 Jun; 16(6):1425-1434. PubMed ID: 34019814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.